Level Chart

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Trikafta / Kaftrio Revenue is at a current level of 2.536B, down from 2.721B last quarter and up from 2.484B one year ago. This is a change of -6.81% from last quarter and 2.09% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 2.536B
Latest Period Mar 2025
Last Updated Jul 31 2025, 08:49 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Average Growth Rate 42.51%
Value from Last Quarter 2.721B
Change from Last Quarter -6.81%
Value from 1 Year Ago 2.484B
Change from 1 Year Ago 2.09%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2025 2.536B
December 31, 2024 2.721B
September 30, 2024 2.585B
June 30, 2024 2.449B
March 31, 2024 2.484B
December 31, 2023 2.333B
September 30, 2023 2.274B
June 30, 2023 2.240B
March 31, 2023 2.097B
December 31, 2022 2.022B
September 30, 2022 2.010B
Date Value
June 30, 2022 1.893B
March 31, 2022 1.762B
December 31, 2021 1.693B
September 30, 2021 1.556B
June 30, 2021 1.256B
March 31, 2021 1.193B
December 31, 2020 1.091B
September 30, 2020 960.00M
June 30, 2020 918.00M
March 31, 2020 895.00M
December 31, 2019 420.00M

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Trikafta / Kaftrio Revenue is at a current level of 2.536B, down from 2.721B last quarter and up from 2.484B one year ago. This is a change of -6.81% from last quarter and 2.09% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 2.536B
Latest Period Mar 2025
Last Updated Jul 31 2025, 08:49 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Average Growth Rate 42.51%
Value from Last Quarter 2.721B
Change from Last Quarter -6.81%
Value from 1 Year Ago 2.484B
Change from 1 Year Ago 2.09%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
VRTX Vertex Pharmaceuticals, Inc. -1.25%